Cytotoxicity in human mucosal and cutaneous leishmaniasis

Area of Science:

• Immunology
• Infectious Diseases

Background:

• CD8+ T cells and lysis of parasitized macrophages are crucial for resistance to leishmaniasis.
• Leishmaniasis is a parasitic disease with significant global health impact.

Purpose of the Study:

• To evaluate the cytotoxic activity of peripheral blood mononuclear cells (PBMC) from leishmaniasis patients.
• To investigate the role of specific cell types and regulatory cytokines in leishmaniasis-induced cytotoxicity.

Main Methods:

• Peripheral blood mononuclear cells (PBMC) from cutaneous (CL) and mucosal leishmaniasis (ML) patients were assessed in cell lysis assays.
• Targets included 51-Cr-labeled Daudi or K562 cells, and autologous antigen-pulsed macrophages.
• Natural killer (NK) cell activity was identified using cell separation techniques.
• The effect of recombinant TGF-beta and IL-10 on cytotoxicity was evaluated.

Main Results:

• Leishmania amazonensis antigen stimulation significantly increased PBMC cytotoxic activity against tumor cell lines (Daudi, K562) and autologous macrophages.
• Mucosal leishmaniasis (ML) patients exhibited higher cytotoxic responses compared to cutaneous leishmaniasis (CL) patients.
• NK cells were identified as the primary mediators of lysis against K562 cells.
• Recombinant TGF-beta and IL-10 markedly reduced Leishmania-induced cytotoxicity.

Conclusions:

• Antigen-specific PBMC cytotoxicity is a feature of leishmaniasis, with higher activity observed in ML.
• NK cells contribute to the lysis of target cells in leishmaniasis patients.
• Regulatory cytokines like TGF-beta and IL-10 play a significant role in suppressing anti-Leishmania immune responses.